Laboratorio Reig Jofre, S.A.

MSE:RJF.MC

2.99 (EUR) • At close July 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 338.895316.088271.15236.231230.079200.207180.468167.983161.134156.9133.28431.3729.92629.48538.841134.616161.019152.91690.76246.98123.219
Cost of Revenue 143.215141.063201.56791.25289.68268.28662.79560.33661.02359.13413.4128.1427.9557.8319.61866.52261.39167.28346.62426.11815.672
Gross Profit 195.68175.02569.583144.979140.397131.921117.673107.647100.11197.77619.87223.22821.97121.65429.22368.09499.62885.63344.13820.8637.547
Gross Profit Ratio 0.5770.5540.2570.6140.610.6590.6520.6410.6210.6230.5970.740.7340.7340.7520.5060.6190.560.4860.4440.325
Reseach & Development Expenses 6.0025.4284.4784.8853.7974.0174.0973.6923.2982.5040.6270.10.06700000000
General & Administrative Expenses 14.5889.7249.0029.2348.42710.1595.4118.82910.318.5390.9943.0713.544000000.34700
Selling & Marketing Expenses 11.95612.96310.9929.0038.38110.1399.8965.4796.5027.1470.2216.5765.99600000000
SG&A 26.54422.68735.29718.23716.80820.29815.30714.30816.81215.6861.2169.6479.54000000.34700
Other Expenses 150.524140.387-20.435112.492109.934101.0489.44180.62470.26167.87715.24311.29211.88626.98736.936-20.97486.2426.81-0.184-0.013.409
Operating Expenses 183.07168.50260.21135.614130.539125.355108.84598.62490.37186.06717.08621.03921.49326.98736.93682.83686.2426.8139.35919.0693.409
Operating Income 12.6110.519.3738.8639.2286.3238.8289.02311.74811.7522.7972.0140.128-16.676-19.166-14.74213.388-13.1794.7791.7943.16
Operating Income Ratio 0.0370.0330.0350.0380.040.0320.0490.0540.0730.0750.0840.0640.004-0.566-0.493-0.110.083-0.0860.0530.0380.136
Total Other Income Expenses Net -0.788-0.014-1.361-3.07-2.802-1.02-0.537-1.020.213-0.745-0.2490.079-1.12827.815-16.645-22.238-8.624-8.7750.183-1.1640.554
Income Before Tax 11.82210.4967.1715.7936.4265.3039.4838.00311.96111.0072.5472.093-116.609-19.508-43.9124.764-3.3921.2550.633.714
Income Before Tax Ratio 0.0350.0330.0260.0250.0280.0260.0530.0480.0740.070.0770.067-0.0330.563-0.502-0.3260.03-0.0220.0140.0130.16
Income Tax Expense 1.3551.0990.6580.7130.760.3640.231-0.8084.2942.2570.2371.14-0.9940.5433.110.995-0.75-0.449-3.294-3.127-0.657
Net Income 10.3829.4078.1075.0925.6724.9429.2668.8287.6768.752.3080.953-0.00616.066-22.618-44.9071.4913.8414.5493.7573.057
Net Income Ratio 0.0310.030.030.0220.0250.0250.0510.0530.0480.0560.0690.03-00.545-0.582-0.3340.0090.0250.050.080.132
EPS 0.130.120.10.0660.0740.0690.140.140.120.010.170.06-01-1.39-2.780.10.60.40.40.33
EPS Diluted 0.130.120.10.0660.0740.0690.140.140.120.010.170.06-01-1.39-2.780.10.60.40.40.33
EBITDA 36.18433.89430.43624.6624.31119.38617.70115.77919.14617.5263.6752.9353.76117.22-11.528-28.9420.25515.4546.1014.6665.577
EBITDA Ratio 0.1070.1070.1120.1040.1060.0970.0980.0940.1190.1120.110.0940.1260.584-0.297-0.2150.1260.1010.0670.0990.24